Impact of ongoing COVID‐19 pandemic on cytology: An institutional experience. Issue 2 (24th September 2020)

• Record Type: Journal Article
• Authors: Rana, Chanchal; Kumar, Sumit; Babu, Suresh; Kushwaha, Rashmi; Singh, Uma S.; Ramakant, Pooja; Singh, Kulranjan; Mishra, Anand
• Is Part Of: Diagnostic cytopathology. Volume 49:Issue 2(2021)
• Page Start: 311
• Page End: 315
• Publication Date: 2020-09-24
• Subjects: COVID‐19 -- cytology -- pandemic; Cytodiagnosis -- Periodicals; Pathology, Cellular -- Periodicals; Cytology -- Periodicals; 616.07582
• DOI: 10.1002/dc.24620
• Languages: English
• ISSNs: 8755-1039

Abstract

Abstract: Background: The ongoing COVID‐19 pandemic has greatly impacted the health services worldwide, challenging the way modern medicine has been practiced for decades. Aim: The present study documents an institutional experience on its impact on cytology services. Materials & Methods: The cytology samples received during lock down period in India (24 March to 17 May 2020) were analysis and compared to the samples received during the same time frame in year 2019. Results: The data revealed an overall 92.6% reduction in cytology samples received. All sample types were reduced with a statically significant reduction in thyroid cytology samples (P‐value: .023). There was relative increase in breast and lymph node samples; however, this relative increase was not statistically significant. The malignancy rate also significantly increased by 34.1% accompanied by decrease in neoplastic category among the samples received during COVID‐19 lockdown period. Breast samples remain the most frequent sample type both in pre‐COVID‐19 and COVID‐19 periods. Majority of fine‐needle aspiration done in these cases, during the lockdown period, were either in cases for recurrence or primary diagnosis. Conclusion: Prioritization of samples, proper precautions and triaging of patients before procedure helped in carrying out this procedure safely.